Vasopressin V2 Receptor Antagonist [EPC]

Vasopressin V2 Receptor Antagonist [EPC] was reported 14926 times

Drugs of the Vasopressin V2 Receptor Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 RAPID CORRECTION OF HYPONATRAEMIA 205 0.8167
1 RENAL CYST RUPTURED 32 0.2370
2 URINE OSMOLARITY DECREASED 19 0.1557
3 POLYCYSTIC LIVER DISEASE 15 0.1415
4 RENAL CYST HAEMORRHAGE 29 0.1283
5 PULMONARY VEIN OCCLUSION 9 0.1111
6 RENAL CYST INFECTION 16 0.1006
7 LOW CARDIAC OUTPUT SYNDROME 30 0.0898
8 URINE OSMOLARITY INCREASED 12 0.0774
9 HYPERNATRAEMIA 367 0.0736
10 DRUG MONITORING PROCEDURE INCORRECTLY PERFORMED 44 0.0664
11 INVESTIGATION NONCOMPLIANCE 7 0.0642
12 FLUID INTAKE RESTRICTION 7 0.0636
13 HEPATIC CYST INFECTION 6 0.0612
14 BLOOD SODIUM INCREASED 165 0.0611
15 THIRST 1011 0.0565
16 POLYURIA 456 0.0556
17 OSMOTIC DEMYELINATION SYNDROME 41 0.0556
18 POLYDIPSIA 212 0.0536
19 BILIRUBIN URINE PRESENT 6 0.0504
20 PULMONARY ARTERIAL WEDGE PRESSURE INCREASED 8 0.0460
21 PROCEDURAL FAILURE 8 0.0449
22 DEFECT CONDUCTION INTRAVENTRICULAR 14 0.0432
23 CYST RUPTURE 26 0.0383
24 CARDIAC FAILURE CHRONIC 158 0.0370
25 LIVER CARCINOMA RUPTURED 8 0.0317
26 CREATININE URINE DECREASED 5 0.0316
27 RENAL TRANSPLANT 114 0.0315
28 HAEMORRHAGIC CYST 12 0.0310
29 CARDIAC OUTPUT INCREASED 5 0.0292
30 IMMOBILISATION SYNDROME 6 0.0282
31 BLOOD SODIUM ABNORMAL 28 0.0263
32 GLOMERULAR FILTRATION RATE DECREASED 314 0.0255
33 NOCTURIA 293 0.0241
34 ASPARTATE AMINOTRANSFERASE DECREASED 12 0.0226
35 URAEMIC ENCEPHALOPATHY 7 0.0224
36 CONGESTIVE HEPATOPATHY 10 0.0223
37 PROTEIN-LOSING GASTROENTEROPATHY 11 0.0221
38 ALANINE AMINOTRANSFERASE DECREASED 16 0.0221
39 BLOOD SODIUM DECREASED 373 0.0198
40 BRAIN NATRIURETIC PEPTIDE INCREASED 60 0.0194
41 MARASMUS 29 0.0191
42 TRANSPLANT 45 0.0189
43 PULMONARY VENO-OCCLUSIVE DISEASE 13 0.0186
44 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 26 0.0185
45 RHYTHM IDIOVENTRICULAR 6 0.0185
46 HYPERURICAEMIA 75 0.0182
47 URINE OUTPUT INCREASED 46 0.0176
48 BLOOD UREA INCREASED 292 0.0174
49 CARBON DIOXIDE DECREASED 20 0.0174
50 BLOOD CHLORIDE INCREASED 30 0.0174
51 KIDNEY ENLARGEMENT 18 0.0165
52 CONGENITAL CYSTIC KIDNEY DISEASE 13 0.0153
53 RIGHT VENTRICULAR FAILURE 107 0.0153
54 BRONCHIAL CARCINOMA 12 0.0152
55 DIALYSIS 216 0.0152
56 BLOOD OSMOLARITY INCREASED 5 0.0152
57 UPPER RESPIRATORY TRACT INFLAMMATION 18 0.0150
58 PRERENAL FAILURE 21 0.0149
59 POLLAKIURIA 602 0.0144
60 HEPATIC ENCEPHALOPATHY 134 0.0143
61 OESOPHAGEAL VARICES HAEMORRHAGE 30 0.0138
62 CARDIAC AMYLOIDOSIS 15 0.0136
63 HEPATORENAL SYNDROME 23 0.0136
64 GLOMERULAR FILTRATION RATE INCREASED 11 0.0133
65 JUGULAR VEIN DISTENSION 7 0.0123
66 CONCOMITANT DISEASE PROGRESSION 24 0.0123
67 CARDIORENAL SYNDROME 7 0.0122
68 COLONOSCOPY 25 0.0113
69 BLOOD OSMOLARITY DECREASED 7 0.0112
70 THIRST DECREASED 7 0.0111
71 RENAL ISCHAEMIA 6 0.0110
72 HYPERCHLORAEMIA 7 0.0109
73 PERITONEAL DIALYSIS 9 0.0109
74 CONCOMITANT DISEASE AGGRAVATED 66 0.0107
75 CARDIAC FAILURE ACUTE 71 0.0106
76 AORTIC VALVE STENOSIS 19 0.0106
77 BLOOD PHOSPHORUS ABNORMAL 5 0.0106
78 HEPATIC CYST 36 0.0106
79 DRUG MONITORING PROCEDURE NOT PERFORMED 19 0.0106
80 HEPATIC CONGESTION 10 0.0106
81 RENAL IMPAIRMENT 884 0.0105
82 ATRIAL TACHYCARDIA 22 0.0105
83 CARDIAC FAILURE 828 0.0103
84 DRUG TITRATION ERROR 26 0.0101
85 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 11 0.0099
86 GLOMERULAR FILTRATION RATE ABNORMAL 14 0.0099
87 BLOOD URIC ACID INCREASED 57 0.0099
88 HEPATIC FUNCTION ABNORMAL 357 0.0096
89 BLOOD ALKALINE PHOSPHATASE DECREASED 9 0.0095
90 SMALL CELL LUNG CANCER 14 0.0093
91 HAEMORRHAGIC INFARCTION 5 0.0091
92 LIVER TRANSPLANT 33 0.0091
93 FLUID INTAKE REDUCED 45 0.0090
94 PULMONARY ARTERIAL HYPERTENSION 130 0.0090
95 URINE OUTPUT DECREASED 77 0.0088
96 CHYLOTHORAX 6 0.0083
97 ISCHAEMIC HEPATITIS 11 0.0080
98 GALLBLADDER POLYP 6 0.0076
99 INFECTED CYST 9 0.0075
100 CYTOMEGALOVIRUS TEST POSITIVE 13 0.0073
101 INCORRECT DRUG ADMINISTRATION RATE 31 0.0073
102 MEDICAL PROCEDURE 12 0.0072
103 BLOOD CREATININE INCREASED 467 0.0071
104 DACTYLITIS 7 0.0071
105 FLUID IMBALANCE 5 0.0071
106 PHYSICAL DECONDITIONING 18 0.0070
107 BLOOD CHLORIDE DECREASED 18 0.0070
108 PULMONARY CONGESTION 92 0.0070
109 INCORRECT DRUG ADMINISTRATION DURATION 196 0.0070
110 INABILITY TO AFFORD MEDICATION 69 0.0069
111 INCORRECT PRODUCT ADMINISTRATION DURATION 148 0.0068
112 UNDERDOSE 498 0.0068
113 CARDIAC OUTPUT DECREASED 6 0.0068
114 ANION GAP INCREASED 9 0.0067
115 NEPHROGENIC ANAEMIA 31 0.0067
116 CATHETER MANAGEMENT 6 0.0067
117 DIABETES INSIPIDUS 16 0.0066
118 CHOLANGITIS ACUTE 5 0.0066
119 DISSEMINATED CRYPTOCOCCOSIS 5 0.0066
120 CEREBRAL ARTERY EMBOLISM 8 0.0066
121 BLOOD POTASSIUM INCREASED 106 0.0065
122 CRITICAL ILLNESS 5 0.0064
123 HYPERCAPNIA 19 0.0063
124 METABOLIC ALKALOSIS 10 0.0062
125 RENAL PAIN 66 0.0062
126 PRESCRIBED UNDERDOSE 123 0.0062
127 HYPOCHLORAEMIA 7 0.0060
128 CARDIAC DYSFUNCTION 22 0.0059
129 LIVER INJURY 138 0.0056
130 HYPONATRAEMIA 316 0.0056
131 CARDIAC ABLATION 10 0.0056
132 ALTERED STATE OF CONSCIOUSNESS 120 0.0055
133 LEFT VENTRICULAR FAILURE 19 0.0055
134 BLOOD PARATHYROID HORMONE INCREASED 16 0.0055
135 SINUS NODE DYSFUNCTION 10 0.0055
136 HYPERKALAEMIA 191 0.0054
137 CARDIAC VENTRICULAR THROMBOSIS 7 0.0054
138 BLOOD UREA ABNORMAL 5 0.0053
139 METABOLIC SURGERY 6 0.0053
140 HYPOPROTEINAEMIA 10 0.0053
141 PRODUCT PRESCRIBING ISSUE 114 0.0052
142 INSURANCE ISSUE 80 0.0052
143 ASPARTATE AMINOTRANSFERASE INCREASED 273 0.0051
144 ALANINE AMINOTRANSFERASE INCREASED 314 0.0051
145 OCCULT BLOOD POSITIVE 10 0.0051
146 BILIARY TRACT DISORDER 7 0.0051
147 HYPERAMMONAEMIA 25 0.0050
148 HEPATOCELLULAR CARCINOMA 38 0.0050
149 CEREBRAL INFARCTION 122 0.0050
150 PSEUDOMEMBRANOUS COLITIS 11 0.0049
151 DRUG DOSE TITRATION NOT PERFORMED 9 0.0049
152 PULMONARY ARTERIAL PRESSURE INCREASED 8 0.0049
153 FLANK PAIN 46 0.0049
154 GASTRIC POLYPS 11 0.0049
155 HEPATIC CIRRHOSIS 90 0.0048
156 ASCITES 139 0.0047
157 HEPATITIS FULMINANT 14 0.0047
158 NEPHRECTOMY 7 0.0047
159 ORTHOPNOEA 15 0.0047
160 PULMONARY HYPERTENSION 98 0.0047
161 LIVER FUNCTION TEST INCREASED 101 0.0047
162 PLATELET TRANSFUSION 6 0.0047
163 BLOOD CREATININE ABNORMAL 16 0.0046
164 GASTROINTESTINAL OEDEMA 8 0.0045
165 AZOTAEMIA 18 0.0045
166 INTRACRANIAL ANEURYSM 18 0.0045
167 RENAL CYST 35 0.0044
168 NEPHROGENIC DIABETES INSIPIDUS 5 0.0043
169 PULMONARY ALVEOLAR HAEMORRHAGE 24 0.0043
170 HYPOALBUMINAEMIA 33 0.0042
171 HERNIA REPAIR 11 0.0042
172 PORTAL HYPERTENSION 13 0.0042
173 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 43 0.0042
174 HYPERPHOSPHATAEMIA 9 0.0042
175 CARDIAC DEATH 5 0.0041
176 BLOOD BILIRUBIN INCREASED 111 0.0041
177 VENTRICULAR HYPOKINESIA 13 0.0040
178 MICTURITION DISORDER 14 0.0040
179 BLOOD UREA DECREASED 5 0.0040
180 HYPOPITUITARISM 7 0.0040
181 HEPATIC FAILURE 121 0.0040
182 IRON DEFICIENCY ANAEMIA 37 0.0040
183 AORTIC VALVE INCOMPETENCE 17 0.0040
184 EMBOLIC STROKE 14 0.0040
185 GLUCOSE URINE PRESENT 5 0.0039
186 VENTRICULAR TACHYCARDIA 64 0.0039
187 ATRIAL THROMBOSIS 8 0.0039
188 TUMOUR HAEMORRHAGE 11 0.0039
189 CONDUCTION DISORDER 7 0.0038
190 INTENTIONAL DOSE OMISSION 107 0.0037
191 LIVER DISORDER 166 0.0037
192 BLOOD PRESSURE SYSTOLIC DECREASED 17 0.0037
193 TRANSFUSION 39 0.0037
194 PROTEIN TOTAL DECREASED 14 0.0037
195 GAMMA-GLUTAMYLTRANSFERASE INCREASED 82 0.0037
196 BLOOD BICARBONATE DECREASED 7 0.0037
197 CARBON DIOXIDE INCREASED 5 0.0037
198 MEAN CELL HAEMOGLOBIN INCREASED 6 0.0036
199 MITRAL VALVE INCOMPETENCE 41 0.0036
200 DEHYDRATION 482 0.0036
201 VENTRICULAR FIBRILLATION 40 0.0036
202 HYPOVOLAEMIA 21 0.0036
203 PNEUMONIA ASPIRATION 89 0.0036
204 OLIGURIA 22 0.0035
205 ENTERITIS INFECTIOUS 6 0.0035
206 DISSEMINATED INTRAVASCULAR COAGULATION 49 0.0035
207 PYELONEPHRITIS 30 0.0035
208 DYSPNOEA AT REST 10 0.0034
209 RENAL HAEMORRHAGE 7 0.0034
210 LUNG OPACITY 9 0.0034
211 PROTEIN URINE PRESENT 17 0.0034
212 BILIARY DILATATION 5 0.0034
213 AORTIC DISSECTION 14 0.0034
214 AMMONIA INCREASED 17 0.0033
215 NEUROGENIC BLADDER 7 0.0033
216 GENERALISED OEDEMA 41 0.0033
217 ASPARTATE AMINOTRANSFERASE ABNORMAL 5 0.0033
218 MEAN CELL HAEMOGLOBIN DECREASED 6 0.0033
219 BLOOD ALKALINE PHOSPHATASE INCREASED 81 0.0033
220 AMYLASE INCREASED 12 0.0032
221 HYPERPARATHYROIDISM SECONDARY 8 0.0032
222 CATHETER SITE INFECTION 12 0.0032
223 GASTROINTESTINAL PERFORATION 13 0.0031
224 END STAGE RENAL DISEASE 57 0.0031
225 EOSINOPHIL COUNT INCREASED 26 0.0031
226 LARGE INTESTINAL HAEMORRHAGE 7 0.0031
227 CYSTITIS INTERSTITIAL 5 0.0031
228 PORTAL VEIN THROMBOSIS 10 0.0031
229 BLOOD PRESSURE DECREASED 205 0.0031
230 BRADYARRHYTHMIA 5 0.0030
231 BLOOD ALBUMIN DECREASED 24 0.0030
232 ANURIA 26 0.0030
233 CARDIOMEGALY 37 0.0030
234 BLOOD POTASSIUM ABNORMAL 8 0.0030
235 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 5 0.0030
236 SMALL INTESTINAL HAEMORRHAGE 6 0.0030
237 CONTRAINDICATED PRODUCT PRESCRIBED 5 0.0030
238 HEPATOTOXICITY 66 0.0030
239 PLEURAL EFFUSION 179 0.0029
240 DRY MOUTH 238 0.0029
241 URINARY HESITATION 7 0.0029
242 BLOOD PHOSPHORUS INCREASED 8 0.0029
243 ENDOCARDITIS 15 0.0029
244 AMYLOIDOSIS 5 0.0029
245 TRICUSPID VALVE INCOMPETENCE 23 0.0029
246 MICTURITION URGENCY 33 0.0029
247 FAECES SOFT 21 0.0029
248 OEDEMA 156 0.0029
249 BLOOD CREATININE DECREASED 9 0.0029
250 ALANINE AMINOTRANSFERASE ABNORMAL 6 0.0028
251 HAEMORRHAGIC DIATHESIS 10 0.0028
252 TRANSAMINASES INCREASED 62 0.0028
253 LUNG CANCER METASTATIC 8 0.0028
254 HAEMOTHORAX 8 0.0028
255 ATRIAL FLUTTER 22 0.0028
256 CANCER PAIN 7 0.0027
257 ESSENTIAL HYPERTENSION 5 0.0027
258 HYPOKALAEMIA 126 0.0027
259 MEAN CELL VOLUME INCREASED 7 0.0027
260 BLOOD CREATINE INCREASED 12 0.0027
261 FAECES PALE 6 0.0027
262 BLOOD POTASSIUM DECREASED 81 0.0027
263 ILEUS PARALYTIC 12 0.0027
264 URINE ANALYSIS ABNORMAL 8 0.0027
265 PROTHROMBIN TIME PROLONGED 16 0.0027
266 THYROIDITIS 8 0.0027
267 TONGUE ULCERATION 9 0.0027
268 NO ADVERSE EVENT 481 0.0027
269 PRODUCT DOSE OMISSION ISSUE 779 0.0026
270 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 535 0.0026
271 HAEMATOCRIT INCREASED 6 0.0026
272 HAEMOGLOBIN INCREASED 12 0.0026
273 INFUSION SITE ERYTHEMA 22 0.0026
274 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 460 0.0025
275 URINE FLOW DECREASED 6 0.0025
276 ENDOTRACHEAL INTUBATION 7 0.0025
277 THERAPY CESSATION 127 0.0025
278 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 176 0.0025
279 PRODUCT DOSE OMISSION IN ERROR 70 0.0025
280 SUBDURAL HAEMATOMA 35 0.0024
281 NEUTROPHIL COUNT INCREASED 25 0.0024
282 INJECTION SITE INFECTION 8 0.0024
283 VASCULAR DEVICE INFECTION 11 0.0024
284 ORGANISING PNEUMONIA 12 0.0024
285 CHOLANGITIS 15 0.0024
286 TACHYARRHYTHMIA 6 0.0024
287 INFUSION SITE SWELLING 15 0.0024
288 HAEMATOCRIT DECREASED 47 0.0024
289 INTESTINAL ISCHAEMIA 13 0.0024
290 RENAL DISORDER 110 0.0024
291 VARICES OESOPHAGEAL 7 0.0023
292 CARDIAC TAMPONADE 11 0.0023
293 HEPATITIS ACUTE 15 0.0023
294 HEPATITIS TOXIC 6 0.0023
295 STAPHYLOCOCCAL BACTERAEMIA 10 0.0023
296 PNEUMONIA BACTERIAL 21 0.0023
297 PRODUCT USE ISSUE 429 0.0023
298 DIABETIC NEPHROPATHY 5 0.0023
299 SUDDEN DEATH 24 0.0023
300 CARDIAC FAILURE CONGESTIVE 182 0.0023
301 HAEMORRHAGE SUBCUTANEOUS 8 0.0023
302 ENTEROCOLITIS 13 0.0022
303 HEPATIC ENZYME INCREASED 153 0.0022
304 BACTERIAL TEST POSITIVE 5 0.0022
305 CIRCULATORY COLLAPSE 38 0.0022
306 HOSPICE CARE 22 0.0022
307 HYPERVOLAEMIA 11 0.0022
308 DIVERTICULUM INTESTINAL HAEMORRHAGIC 5 0.0022
309 CARDIAC OPERATION 19 0.0022
310 SCLERODERMA 8 0.0022
311 URINE ABNORMALITY 10 0.0022
312 MULTIPLE ORGAN DYSFUNCTION SYNDROME 62 0.0022
313 NEPHROTIC SYNDROME 15 0.0022
314 BUNDLE BRANCH BLOCK RIGHT 10 0.0022
315 SKIN EROSION 7 0.0022
316 LARGE INTESTINE POLYP 15 0.0022
317 DRUG ERUPTION 38 0.0021
318 LISTLESS 7 0.0021
319 SEPTIC SHOCK 92 0.0021
320 HIGH DENSITY LIPOPROTEIN DECREASED 7 0.0021
321 DUODENAL ULCER HAEMORRHAGE 6 0.0021
322 LYMPHOCYTE COUNT DECREASED 37 0.0021
323 DEVICE RELATED INFECTION 32 0.0021
324 ELECTROLYTE IMBALANCE 24 0.0021
325 DIZZINESS POSTURAL 20 0.0021
326 SUDDEN CARDIAC DEATH 7 0.0021
327 COMPRESSION FRACTURE 11 0.0021
328 PLATELET COUNT DECREASED 218 0.0020
329 VENTRICULAR EXTRASYSTOLES 21 0.0020
330 PRODUCT USE IN UNAPPROVED INDICATION 501 0.0020
331 COLON CANCER 30 0.0020
332 GOUT 36 0.0020
333 CREATININE RENAL CLEARANCE DECREASED 8 0.0020
334 KIDNEY INFECTION 39 0.0020
335 INTERSTITIAL LUNG DISEASE 96 0.0020
336 DRUG-INDUCED LIVER INJURY 62 0.0020
337 FIBRIN D DIMER INCREASED 7 0.0020
338 DISEASE COMPLICATION 9 0.0020
339 ACIDOSIS 15 0.0020
340 RED BLOOD CELL COUNT DECREASED 56 0.0020
341 PRODUCT DISTRIBUTION ISSUE 18 0.0019
342 RENAL FUNCTION TEST ABNORMAL 9 0.0019
343 SPINAL COMPRESSION FRACTURE 16 0.0019
344 LIPOMA 5 0.0019
345 MONOCYTE COUNT INCREASED 7 0.0019
346 HAEMATURIA 66 0.0019
347 RED CELL DISTRIBUTION WIDTH INCREASED 8 0.0019
348 CONGESTIVE CARDIOMYOPATHY 8 0.0019
349 FACE OEDEMA 32 0.0019
350 RALES 11 0.0019
351 SUPRAVENTRICULAR TACHYCARDIA 18 0.0019
352 BLOOD CREATINE PHOSPHOKINASE INCREASED 54 0.0019
353 ACUTE KIDNEY INJURY 287 0.0019
354 SHOULDER OPERATION 8 0.0019
355 MYCOBACTERIUM AVIUM COMPLEX INFECTION 5 0.0019
356 HYPOXIA 65 0.0018
357 LABORATORY TEST ABNORMAL 54 0.0018
358 WRONG TECHNIQUE IN DRUG USAGE PROCESS 66 0.0018
359 ADRENAL INSUFFICIENCY 22 0.0018
360 HEPATIC ENZYME ABNORMAL 9 0.0018
361 ANAL HAEMORRHAGE 5 0.0018
362 LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV 6 0.0018
363 BLOOD CALCIUM DECREASED 20 0.0018
364 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 9 0.0018
365 PNEUMONIA FUNGAL 7 0.0018
366 BACTERAEMIA 21 0.0018
367 OESOPHAGEAL CANDIDIASIS 7 0.0018
368 IMMUNE THROMBOCYTOPENIA 8 0.0017
369 EYE OPERATION 8 0.0017
370 HYSTERECTOMY 15 0.0017
371 ADENOVIRUS INFECTION 5 0.0017
372 SHOCK HAEMORRHAGIC 14 0.0017
373 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 7 0.0017
374 UMBILICAL HERNIA 8 0.0017
375 HAEMOGLOBIN ABNORMAL 11 0.0017
376 SHOCK 39 0.0017
377 THERAPY INTERRUPTED 121 0.0017
378 ILEUS 21 0.0017
379 CONJUNCTIVAL HYPERAEMIA 6 0.0017
380 DEPRESSED LEVEL OF CONSCIOUSNESS 66 0.0017
381 HAEMODIALYSIS 14 0.0017
382 LUNG ADENOCARCINOMA 5 0.0017
383 BUNDLE BRANCH BLOCK LEFT 7 0.0016
384 ATRIOVENTRICULAR BLOCK SECOND DEGREE 5 0.0016
385 DYSPNOEA EXERTIONAL 62 0.0016
386 PERICARDIAL EFFUSION 38 0.0016
387 BLOOD LACTATE DEHYDROGENASE INCREASED 26 0.0016
388 VENTRICULAR ARRHYTHMIA 6 0.0016
389 DYSCHEZIA 5 0.0016
390 MELAENA 36 0.0016
391 FLUID RETENTION 82 0.0016
392 SURGERY 94 0.0016
393 HYDRONEPHROSIS 12 0.0016
394 DIVERTICULUM INTESTINAL 7 0.0016
395 URINARY RETENTION 53 0.0016
396 CHOLECYSTITIS ACUTE 9 0.0016
397 HAEMOPTYSIS 44 0.0016
398 GASTROENTERITIS 23 0.0016
399 TONGUE OEDEMA 6 0.0016
400 SUBARACHNOID HAEMORRHAGE 16 0.0016
401 HAEMOLYTIC ANAEMIA 14 0.0016
402 FEMORAL NECK FRACTURE 8 0.0016
403 SLEEP DISORDER 110 0.0016
404 HEPATIC STEATOSIS 29 0.0016
405 GASTROENTERITIS VIRAL 28 0.0015
406 HAEMOGLOBIN DECREASED 159 0.0015
407 LIVER FUNCTION TEST ABNORMAL 45 0.0015
408 BLOOD URINE PRESENT 29 0.0015
409 NEPHROPATHY TOXIC 17 0.0015
410 CHOLECYSTITIS 18 0.0015
411 TREATMENT NONCOMPLIANCE 82 0.0015
412 DECREASED APPETITE 348 0.0015
413 LOWER GASTROINTESTINAL HAEMORRHAGE 11 0.0015
414 RESPIRATORY FAILURE 108 0.0015
415 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 9 0.0015
416 SEPSIS 165 0.0015
417 PANCYTOPENIA 81 0.0014
418 CERVICAL VERTEBRAL FRACTURE 5 0.0014
419 HYPERBILIRUBINAEMIA 15 0.0014
420 GASTRIC ULCER HAEMORRHAGE 8 0.0014
421 DIVERTICULITIS 40 0.0014
422 OROPHARYNGEAL DISCOMFORT 13 0.0014
423 RENAL FAILURE 191 0.0014
424 LIPASE INCREASED 11 0.0014
425 HAEMORRHOIDAL HAEMORRHAGE 7 0.0014
426 PULMONARY OEDEMA 64 0.0014
427 ATRIAL FIBRILLATION 139 0.0014
428 STAPHYLOCOCCAL SEPSIS 7 0.0014
429 VENOOCCLUSIVE LIVER DISEASE 7 0.0014
430 CHROMATURIA 32 0.0014
431 FOOT OPERATION 7 0.0014
432 ABDOMINAL TENDERNESS 7 0.0014
433 WHITE BLOOD CELL COUNT INCREASED 54 0.0014
434 ANEURYSM 7 0.0014
435 CHOLECYSTECTOMY 16 0.0014
436 ARTERIAL OCCLUSIVE DISEASE 11 0.0014
437 ACUTE HEPATIC FAILURE 19 0.0014
438 HEPATIC LESION 6 0.0014
439 PNEUMOTHORAX 22 0.0014
440 ANAEMIA 264 0.0014
441 CORONARY ARTERIAL STENT INSERTION 7 0.0014
442 OEDEMA PERIPHERAL 168 0.0014
443 DYSLIPIDAEMIA 7 0.0014
444 ORTHOSTATIC HYPOTENSION 24 0.0014
445 REFUSAL OF TREATMENT BY PATIENT 9 0.0014
446 HYPERTRIGLYCERIDAEMIA 8 0.0014
447 CYTOMEGALOVIRUS VIRAEMIA 6 0.0013
448 ADVERSE EVENT 124 0.0013
449 FAECES DISCOLOURED 29 0.0013
450 PRODUCT SUBSTITUTION ISSUE 77 0.0013
451 RENAL TUBULAR NECROSIS 13 0.0013
452 CARDIOGENIC SHOCK 19 0.0013
453 HEPATOMEGALY 13 0.0013
454 THERAPY CHANGE 13 0.0013
455 CHEMOTHERAPY 5 0.0013
456 ABDOMINAL HERNIA 6 0.0013
457 HAEMODYNAMIC INSTABILITY 10 0.0013
458 DELIRIUM 45 0.0013
459 CHRONIC KIDNEY DISEASE 98 0.0013
460 FAECES HARD 5 0.0013
461 MUSCLE RUPTURE 5 0.0013
462 HYPOTHYROIDISM 41 0.0013
463 PULMONARY HAEMORRHAGE 10 0.0013
464 DUODENAL ULCER 9 0.0013
465 ABDOMINAL DISTENSION 133 0.0013
466 SYNCOPE 127 0.0013
467 CARDIO-RESPIRATORY ARREST 53 0.0013
468 BRADYCARDIA 67 0.0013
469 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 9 0.0013
470 HOSPITALISATION 193 0.0013
471 HUMERUS FRACTURE 6 0.0012
472 ATELECTASIS 12 0.0012
473 FEEDING DISORDER 25 0.0012
474 PNEUMONIA 399 0.0012
475 THROMBOTIC MICROANGIOPATHY 12 0.0012
476 GASTROINTESTINAL HAEMORRHAGE 102 0.0012
477 BREATH SOUNDS ABNORMAL 6 0.0012
478 DEATH 1042 0.0012
479 STRESS CARDIOMYOPATHY 7 0.0012
480 HYPOTENSION 241 0.0012
481 DYSURIA 44 0.0012
482 ATRIOVENTRICULAR BLOCK COMPLETE 8 0.0012
483 PEMPHIGOID 9 0.0012
484 TOXIC SKIN ERUPTION 12 0.0012
485 HAEMATEMESIS 30 0.0012
486 PRODUCT PRESCRIBING ERROR 28 0.0012
487 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 6 0.0012
488 LEFT VENTRICULAR HYPERTROPHY 5 0.0012
489 ILLNESS 120 0.0012
490 LYMPHOMA 18 0.0012
491 INFUSION SITE PAIN 15 0.0012
492 CARDIAC ARREST 96 0.0012
493 JAUNDICE 31 0.0012
494 HYPERTRANSAMINASAEMIA 8 0.0011
495 BLOOD CALCIUM INCREASED 10 0.0011
496 FOOD CRAVING 6 0.0011
497 BLOOD TEST ABNORMAL 16 0.0011
498 INTERNAL HAEMORRHAGE 13 0.0011
499 SERUM FERRITIN INCREASED 6 0.0011
500 HAEMORRHAGIC ANAEMIA 5 0.0011
501 HYPOPHAGIA 29 0.0011
502 CATHETERISATION CARDIAC 5 0.0011
503 C-REACTIVE PROTEIN INCREASED 41 0.0011
504 NEPHROLITHIASIS 51 0.0011
505 HIP SURGERY 6 0.0011
506 CLOSTRIDIUM DIFFICILE INFECTION 24 0.0011
507 ARRHYTHMIA 52 0.0011
508 LUMBAR VERTEBRAL FRACTURE 5 0.0011
509 URINARY TRACT INFECTION 186 0.0011
510 PERITONITIS BACTERIAL 11 0.0011
511 ACUTE CORONARY SYNDROME 9 0.0011
512 LOCALISED OEDEMA 5 0.0011
513 NEPHROPATHY 10 0.0011
514 MIDDLE INSOMNIA 20 0.0011
515 ACUTE PULMONARY OEDEMA 6 0.0011
516 OXYGEN SATURATION DECREASED 60 0.0011
517 HYPOCALCAEMIA 20 0.0011
518 APPETITE DISORDER 7 0.0011
519 TROPONIN INCREASED 8 0.0011
520 ACUTE MYOCARDIAL INFARCTION 31 0.0011
521 CARDIAC VALVE DISEASE 6 0.0010
522 BLOOD MAGNESIUM DECREASED 9 0.0010
523 LIMB OPERATION 5 0.0010
524 MULTI-ORGAN FAILURE 18 0.0010
525 ACUTE RESPIRATORY FAILURE 20 0.0010
526 COLITIS ISCHAEMIC 7 0.0010
527 METASTASES TO LYMPH NODES 7 0.0010
528 LOW DENSITY LIPOPROTEIN INCREASED 8 0.0010
529 BRONCHOPULMONARY ASPERGILLOSIS 8 0.0010
530 EJECTION FRACTION DECREASED 16 0.0010
531 BRAIN FOG 16 0.0010
532 DECREASED ACTIVITY 11 0.0010
533 INTERNATIONAL NORMALISED RATIO INCREASED 29 0.0010
534 OFF LABEL USE 888 0.0010
535 LYMPHOEDEMA 7 0.0010
536 BLOOD IRON DECREASED 12 0.0010
537 LARGE INTESTINE PERFORATION 7 0.0010
538 ASPIRATION 11 0.0010
539 FRACTURE 19 0.0010
540 LUNG NEOPLASM MALIGNANT 41 0.0010
541 PRODUCT DOSE OMISSION 65 0.0010
542 HEPATITIS C 12 0.0010
543 MALNUTRITION 11 0.0010
544 NEUTROPHIL COUNT DECREASED 40 0.0010
545 MYELODYSPLASTIC SYNDROME 14 0.0010
546 HYPERTHYROIDISM 14 0.0010
547 ERYTHEMA MULTIFORME 9 0.0010
548 DERMATITIS CONTACT 11 0.0010
549 CEREBRAL HAEMORRHAGE 34 0.0009
550 PROTEINURIA 18 0.0009
551 FOOD POISONING 5 0.0009
552 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 7 0.0009
553 CARDIAC FLUTTER 6 0.0009
554 ANGIOEDEMA 41 0.0009
555 HIATUS HERNIA 12 0.0009
556 INJECTION SITE INDURATION 12 0.0009
557 CARDIAC MURMUR 8 0.0009
558 OESOPHAGITIS 10 0.0009
559 AGRANULOCYTOSIS 17 0.0009
560 CORONAVIRUS INFECTION 6 0.0009
561 HAEMOLYSIS 7 0.0009
562 HYPERGLYCAEMIA 33 0.0009
563 ATRIOVENTRICULAR BLOCK 7 0.0009
564 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 8 0.0009
565 PURPURA 8 0.0009
566 CONSTIPATION 197 0.0009
567 BRAIN INJURY 9 0.0009
568 LEFT VENTRICULAR DYSFUNCTION 6 0.0009
569 FLUID OVERLOAD 13 0.0009
570 EATING DISORDER 19 0.0009
571 LIP DRY 8 0.0009
572 EXERCISE TOLERANCE DECREASED 5 0.0009
573 HYPOGLYCAEMIA 42 0.0009
574 TOXIC EPIDERMAL NECROLYSIS 13 0.0009
575 NEOPLASM MALIGNANT 57 0.0009
576 SPLENOMEGALY 10 0.0009
577 CELLULITIS 43 0.0009
578 ARTERIOSCLEROSIS 8 0.0008
579 BLOOD TRIGLYCERIDES INCREASED 15 0.0008
580 CYTOKINE RELEASE SYNDROME 17 0.0008
581 GENERAL PHYSICAL HEALTH DETERIORATION 98 0.0008
582 CATARACT OPERATION 5 0.0008
583 HEMIPLEGIA 7 0.0008
584 PRODUCT SUPPLY ISSUE 6 0.0008
585 CARDIAC PACEMAKER INSERTION 5 0.0008
586 DRUG INTERACTION 133 0.0008
587 TASTE DISORDER 17 0.0008
588 DRUG PRESCRIBING ERROR 16 0.0008
589 HAEMORRHOIDS 16 0.0008
590 RHABDOMYOLYSIS 34 0.0008
591 SPINAL OPERATION 10 0.0008
592 WEIGHT INCREASED 181 0.0008
593 PYREXIA 279 0.0008
594 RESPIRATORY DISORDER 24 0.0008
595 INTESTINAL PERFORATION 9 0.0008
596 PERIPHERAL COLDNESS 11 0.0008
597 CONTRAINDICATED PRODUCT ADMINISTERED 24 0.0008
598 BRAIN OEDEMA 10 0.0008
599 GASTRIC CANCER 20 0.0008
600 CONDITION AGGRAVATED 240 0.0008
601 DRY THROAT 8 0.0008
602 DISEASE PROGRESSION 93 0.0008
603 CYSTITIS 25 0.0008
604 HEPATITIS 20 0.0008
605 ANAL INCONTINENCE 7 0.0008
606 PAIN IN JAW 22 0.0008
607 UPPER GASTROINTESTINAL HAEMORRHAGE 13 0.0008
608 TENDERNESS 8 0.0008
609 TORSADE DE POINTES 6 0.0008
610 STEVENS-JOHNSON SYNDROME 17 0.0008
611 BRAIN NEOPLASM 7 0.0008
612 UROSEPSIS 7 0.0008
613 LOSS OF CONSCIOUSNESS 97 0.0008
614 INCONTINENCE 8 0.0008
615 MENTAL STATUS CHANGES 21 0.0008
616 HAEMATOCHEZIA 41 0.0007
617 METASTASES TO LIVER 13 0.0007
618 PULMONARY MASS 11 0.0007
619 HYPERCALCAEMIA 9 0.0007
620 GALLBLADDER DISORDER 13 0.0007
621 DRUG LEVEL INCREASED 12 0.0007
622 AUTOIMMUNE HEPATITIS 5 0.0007
623 BLOOD PRESSURE SYSTOLIC INCREASED 14 0.0007
624 MUSCLE ATROPHY 9 0.0007
625 WHITE BLOOD CELL COUNT DECREASED 77 0.0007
626 URINARY INCONTINENCE 21 0.0007
627 HEPATIC CANCER 17 0.0007
628 RENAL FAILURE ACUTE 30 0.0007
629 DYSPHAGIA 67 0.0007
630 BLADDER DISORDER 7 0.0007
631 MYOCARDIAL ISCHAEMIA 8 0.0007
632 NEUTROPENIC SEPSIS 5 0.0007
633 DIZZINESS 349 0.0007
634 PNEUMOCYSTIS JIROVECII PNEUMONIA 7 0.0007
635 BACTERIAL INFECTION 13 0.0007
636 GRAFT VERSUS HOST DISEASE 5 0.0007
637 EPISTAXIS 52 0.0007
638 ENCEPHALOPATHY 17 0.0007
639 WEIGHT DECREASED 193 0.0007
640 VIRAL INFECTION 23 0.0007
641 MALAISE 303 0.0007
642 INFLUENZA 77 0.0007
643 PLATELET COUNT INCREASED 9 0.0007
644 RESPIRATORY ARREST 19 0.0007
645 HYPOKINESIA 10 0.0007
646 POST PROCEDURAL HAEMORRHAGE 8 0.0007
647 INTENTIONAL UNDERDOSE 5 0.0007
648 GROIN PAIN 6 0.0007
649 ACUTE RESPIRATORY DISTRESS SYNDROME 12 0.0007
650 CARDIOMYOPATHY 10 0.0007
651 DRY SKIN 90 0.0007
652 HERNIA 13 0.0007
653 INFECTION 96 0.0007
654 ANGINA PECTORIS 19 0.0007
655 PRODUCT AVAILABILITY ISSUE 15 0.0007
656 NO THERAPEUTIC RESPONSE 8 0.0007
657 ABDOMINAL PAIN 151 0.0006
658 MUSCULOSKELETAL CHEST PAIN 10 0.0006
659 INJECTION SITE DISCOLOURATION 8 0.0006
660 GASTROOESOPHAGEAL REFLUX DISEASE 51 0.0006
661 NEOPLASM PROGRESSION 22 0.0006
662 RIB FRACTURE 13 0.0006
663 GASTRIC ULCER 12 0.0006
664 CARDIAC DISORDER 59 0.0006
665 HYPERTENSION 133 0.0006
666 EOSINOPHILIA 11 0.0006
667 HEPATIC CYTOLYSIS 8 0.0006
668 METABOLIC ACIDOSIS 20 0.0006
669 PANCREATITIS ACUTE 14 0.0006
670 DYSPEPSIA 61 0.0006
671 KNEE ARTHROPLASTY 13 0.0006
672 PRESYNCOPE 15 0.0006
673 FEMUR FRACTURE 19 0.0006
674 DIARRHOEA 395 0.0006
675 DYSPNOEA 346 0.0006
676 MYOCARDITIS 7 0.0006
677 KNEE OPERATION 6 0.0006
678 CHOLELITHIASIS 20 0.0006
679 ILL-DEFINED DISORDER 37 0.0006
680 DEMENTIA 17 0.0006
681 GASTRITIS 16 0.0006
682 DRUG EFFECT LESS THAN EXPECTED 9 0.0006
683 STAPHYLOCOCCAL INFECTION 20 0.0006
684 PALPITATIONS 71 0.0006
685 MENSTRUAL DISORDER 5 0.0006
686 BLOOD PRESSURE ABNORMAL 12 0.0006
687 EYELID OEDEMA 7 0.0006
688 DRUG INTOLERANCE 58 0.0006
689 HEAD INJURY 19 0.0006
690 SEIZURE 69 0.0006
691 VOMITING 280 0.0006
692 BLOOD PRESSURE INCREASED 91 0.0006
693 GLYCOSYLATED HAEMOGLOBIN INCREASED 15 0.0006
694 ECONOMIC PROBLEM 9 0.0006
695 TACHYPNOEA 8 0.0006
696 INTESTINAL OBSTRUCTION 22 0.0006
697 DISORIENTATION 23 0.0006
698 FOOT FRACTURE 11 0.0006
699 MUSCLE STRAIN 5 0.0006
700 RESPIRATORY TRACT INFECTION 15 0.0006
701 FEELING COLD 16 0.0006
702 LOWER LIMB FRACTURE 11 0.0006
703 FALL 190 0.0006
704 BLOOD GLUCOSE INCREASED 107 0.0006
705 PLASMA CELL MYELOMA 22 0.0006
706 INTENTIONAL PRODUCT USE ISSUE 49 0.0006
707 NAUSEA 442 0.0006
708 IMPAIRED QUALITY OF LIFE 8 0.0006
709 PULMONARY THROMBOSIS 6 0.0005
710 GASTROINTESTINAL PAIN 6 0.0005
711 ERECTILE DYSFUNCTION 14 0.0005
712 CONFUSIONAL STATE 88 0.0005
713 ABDOMINAL PAIN UPPER 112 0.0005
714 BLOOD THYROID STIMULATING HORMONE INCREASED 5 0.0005
715 FATIGUE 423 0.0005
716 PERICARDITIS 9 0.0005
717 INCORRECT DOSE ADMINISTERED 122 0.0005
718 TUBULOINTERSTITIAL NEPHRITIS 10 0.0005
719 DYSARTHRIA 20 0.0005
720 REBOUND EFFECT 6 0.0005
721 LEUKAEMIA 5 0.0005
722 DERMATITIS 11 0.0005
723 EPILEPSY 16 0.0005
724 HIP ARTHROPLASTY 8 0.0005
725 MYOCARDIAL INFARCTION 91 0.0005
726 LETHARGY 30 0.0005
727 BLOOD GLUCOSE DECREASED 25 0.0005
728 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 27 0.0005
729 NASOPHARYNGITIS 95 0.0005
730 IMPAIRED GASTRIC EMPTYING 7 0.0005
731 CHOKING 10 0.0005
732 POOR QUALITY SLEEP 11 0.0005
733 DEPRESSED MOOD 27 0.0005
734 ASTHENIA 191 0.0005
735 INSOMNIA 135 0.0005
736 LIGAMENT SPRAIN 5 0.0005
737 BACK PAIN 117 0.0005
738 HYPOMAGNESAEMIA 7 0.0005
739 HEADACHE 313 0.0005
740 HYPOTHERMIA 5 0.0005
741 PRURITUS 189 0.0005
742 HEART RATE DECREASED 17 0.0005
743 PERITONITIS 10 0.0005
744 CYTOMEGALOVIRUS INFECTION 8 0.0005
745 COAGULOPATHY 8 0.0005
746 MUSCLE SPASMS 88 0.0005
747 MALIGNANT NEOPLASM PROGRESSION 49 0.0005
748 FOLLICULITIS 5 0.0005
749 PERIPHERAL SWELLING 73 0.0005
750 TACHYCARDIA 42 0.0005
751 MYELOSUPPRESSION 17 0.0005
752 CLOSTRIDIUM DIFFICILE COLITIS 5 0.0005
753 COVID-19 82 0.0005
754 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 8 0.0005
755 METASTASES TO CENTRAL NERVOUS SYSTEM 6 0.0005
756 PRESCRIBED OVERDOSE 9 0.0005
757 HAEMATOMA 12 0.0005
758 SKIN FISSURES 9 0.0005
759 COLD SWEAT 8 0.0005
760 DIABETES MELLITUS INADEQUATE CONTROL 8 0.0005
761 EYE HAEMORRHAGE 6 0.0004
762 HYPERTENSIVE CRISIS 5 0.0004
763 DIABETES MELLITUS 34 0.0004
764 PRODUCT ADMINISTRATION ERROR 9 0.0004
765 OSTEOMYELITIS 8 0.0004
766 HAEMORRHAGE 46 0.0004
767 SWELLING 41 0.0004
768 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 21 0.0004
769 THROMBOSIS 35 0.0004
770 ABDOMINAL PAIN LOWER 11 0.0004
771 GASTRIC HAEMORRHAGE 5 0.0004
772 CHEST PAIN 80 0.0004
773 DRUG RESISTANCE 11 0.0004
774 MOUTH ULCERATION 9 0.0004
775 ANAPHYLACTIC SHOCK 11 0.0004
776 SEASONAL ALLERGY 6 0.0004
777 COVID-19 PNEUMONIA 5 0.0004
778 DEAFNESS 11 0.0004
779 PARALYSIS 6 0.0004
780 HYPERLIPIDAEMIA 5 0.0004
781 PULMONARY FIBROSIS 8 0.0004
782 CHOLESTASIS 8 0.0004
783 BLOOD PRESSURE FLUCTUATION 10 0.0004
784 PANCREATITIS 22 0.0004
785 DEEP VEIN THROMBOSIS 27 0.0004
786 GLAUCOMA 8 0.0004
787 CANDIDA INFECTION 7 0.0004
788 RESTLESSNESS 15 0.0004
789 MUSCULOSKELETAL DISCOMFORT 7 0.0004
790 ROAD TRAFFIC ACCIDENT 17 0.0004
791 ABDOMINAL DISCOMFORT 68 0.0004
792 LIMB INJURY 11 0.0004
793 RASH MACULO-PAPULAR 9 0.0004
794 UPPER LIMB FRACTURE 8 0.0004
795 FEELING ABNORMAL 96 0.0004
796 COUGH 112 0.0004
797 COMA 19 0.0004
798 CORONARY ARTERY DISEASE 12 0.0004
799 CEREBROVASCULAR ACCIDENT 67 0.0004
800 BONE MARROW FAILURE 8 0.0004
801 GASTROINTESTINAL DISORDER 35 0.0004
802 MENTAL DISORDER 17 0.0004
803 MUSCULAR WEAKNESS 44 0.0004
804 SKIN ULCER 10 0.0004
805 CATARACT 23 0.0004
806 DRUG EFFECT INCOMPLETE 14 0.0004
807 HERPES ZOSTER 22 0.0004
808 PANCREATIC CARCINOMA 11 0.0004
809 SOMNOLENCE 76 0.0004
810 VERTIGO 23 0.0004
811 SCIATICA 6 0.0004
812 DRUG DOSE OMISSION 61 0.0004
813 LUNG DISORDER 18 0.0004
814 LYMPHADENOPATHY 13 0.0004
815 METASTASES TO BONE 6 0.0004
816 BRONCHITIS 27 0.0004
817 CONTUSION 35 0.0004
818 FUNGAL INFECTION 12 0.0004
819 THROMBOCYTOPENIA 40 0.0004
820 ADVERSE DRUG REACTION 32 0.0004
821 PRODUCTIVE COUGH 17 0.0004
822 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 25 0.0004
823 FEBRILE NEUTROPENIA 23 0.0003
824 BLOOD CHOLESTEROL INCREASED 16 0.0003
825 RHINORRHOEA 22 0.0003
826 IMMUNODEFICIENCY 5 0.0003
827 MIGRAINE 32 0.0003
828 HEART RATE INCREASED 33 0.0003
829 JOINT INJURY 7 0.0003
830 IMPAIRED WORK ABILITY 7 0.0003
831 DRUG ADMINISTRATION ERROR 10 0.0003
832 ABORTION SPONTANEOUS 13 0.0003
833 ACUTE MYELOID LEUKAEMIA 5 0.0003
834 CYANOSIS 5 0.0003
835 CONVULSION 18 0.0003
836 SLEEP APNOEA SYNDROME 6 0.0003
837 MATERNAL EXPOSURE DURING PREGNANCY 28 0.0003
838 INCREASED APPETITE 6 0.0003
839 POST PROCEDURAL COMPLICATION 6 0.0003
840 INFLAMMATION 16 0.0003
841 RASH GENERALISED 8 0.0003
842 ELECTROCARDIOGRAM QT PROLONGED 11 0.0003
843 SPEECH DISORDER 16 0.0003
844 DEPRESSION 69 0.0003
845 SINUSITIS 31 0.0003
846 DRY EYE 15 0.0003
847 FULL BLOOD COUNT DECREASED 6 0.0003
848 PRODUCT PHYSICAL ISSUE 6 0.0003
849 PAIN OF SKIN 8 0.0003
850 THERAPEUTIC RESPONSE DECREASED 18 0.0003
851 STOMATITIS 18 0.0003
852 TRANSIENT ISCHAEMIC ATTACK 10 0.0003
853 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 10 0.0003
854 PULMONARY EMBOLISM 28 0.0003
855 PNEUMONITIS 8 0.0003
856 CHEST DISCOMFORT 30 0.0003
857 HOT FLUSH 22 0.0003
858 MENTAL IMPAIRMENT 7 0.0003
859 WHEEZING 17 0.0003
860 MUSCULOSKELETAL PAIN 15 0.0003
861 LOWER RESPIRATORY TRACT INFECTION 13 0.0003
862 SKIN DISCOLOURATION 13 0.0003
863 DYSGEUSIA 21 0.0003
864 HEAD DISCOMFORT 5 0.0003
865 UPPER RESPIRATORY TRACT INFECTION 13 0.0003
866 BALANCE DISORDER 24 0.0003
867 ACCIDENTAL OVERDOSE 10 0.0003
868 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 15 0.0003
869 EXTRA DOSE ADMINISTERED 11 0.0003
870 SKIN DISORDER 9 0.0003
871 OSTEOPOROSIS 11 0.0003
872 HEART RATE IRREGULAR 6 0.0003
873 APHASIA 8 0.0003
874 FLATULENCE 15 0.0003
875 DISCOMFORT 16 0.0003
876 RASH 114 0.0003
877 MENSTRUATION IRREGULAR 7 0.0003
878 TINNITUS 12 0.0003
879 OROPHARYNGEAL PAIN 24 0.0003
880 GYNAECOMASTIA 8 0.0003
881 RASH MACULAR 9 0.0003
882 NERVOUS SYSTEM DISORDER 8 0.0003
883 HYPOACUSIS 11 0.0003
884 NASAL CONGESTION 15 0.0003
885 MEDICATION ERROR 14 0.0003
886 ECZEMA 13 0.0002
887 NIGHT SWEATS 8 0.0002
888 INJECTION SITE WARMTH 5 0.0002
889 VISUAL ACUITY REDUCED 8 0.0002
890 JOINT SWELLING 29 0.0002
891 MEMORY IMPAIRMENT 33 0.0002
892 LEUKOPENIA 12 0.0002
893 CHILLS 28 0.0002
894 HALLUCINATION 18 0.0002
895 CARDIOVASCULAR DISORDER 6 0.0002
896 IRRITABLE BOWEL SYNDROME 5 0.0002
897 UNRESPONSIVE TO STIMULI 6 0.0002
898 DISEASE RECURRENCE 11 0.0002
899 MYALGIA 39 0.0002
900 TREMOR 38 0.0002
901 INTERVERTEBRAL DISC PROTRUSION 5 0.0002
902 INTENTIONAL PRODUCT MISUSE 20 0.0002
903 FEELING HOT 14 0.0002
904 PAIN IN EXTREMITY 67 0.0002
905 LIMB DISCOMFORT 7 0.0002
906 SKIN EXFOLIATION 19 0.0002
907 THROAT IRRITATION 10 0.0002
908 FREQUENT BOWEL MOVEMENTS 6 0.0002
909 RASH PRURITIC 12 0.0002
910 HYPOAESTHESIA 33 0.0002
911 OVERDOSE 47 0.0002
912 HIP FRACTURE 7 0.0002
913 ABNORMAL DREAMS 6 0.0002
914 PROCEDURAL PAIN 6 0.0002
915 LACTIC ACIDOSIS 7 0.0002
916 SWELLING FACE 14 0.0002
917 WOUND 6 0.0002
918 LIP SWELLING 7 0.0002
919 HYPERHIDROSIS 27 0.0002
920 RECTAL HAEMORRHAGE 9 0.0002
921 ERYTHEMA 43 0.0002
922 GAIT DISTURBANCE 40 0.0002
923 TYPE 2 DIABETES MELLITUS 7 0.0002
924 NEURALGIA 5 0.0002
925 DYSSTASIA 6 0.0002
926 DYSPHONIA 12 0.0002
927 AGITATION 15 0.0002
928 DRUG INEFFECTIVE 266 0.0002
929 AMNESIA 13 0.0002
930 NEUTROPENIA 27 0.0002
931 UNEVALUABLE EVENT 15 0.0002
932 DYSKINESIA 8 0.0002
933 NECK PAIN 11 0.0002
934 EMOTIONAL DISORDER 6 0.0002
935 DIPLOPIA 5 0.0002
936 SWOLLEN TONGUE 6 0.0002
937 MUCOSAL INFLAMMATION 5 0.0002
938 EAR INFECTION 5 0.0002
939 ASTHMA 21 0.0002
940 PAIN 114 0.0002
941 ARTHRALGIA 75 0.0002
942 THERAPEUTIC PRODUCT EFFECT DECREASED 8 0.0002
943 EXPOSURE DURING PREGNANCY 11 0.0002
944 HYPERSENSITIVITY 32 0.0002
945 SYSTEMIC LUPUS ERYTHEMATOSUS 6 0.0002
946 INCORRECT ROUTE OF DRUG ADMINISTRATION 6 0.0002
947 RASH ERYTHEMATOUS 8 0.0002
948 INFUSION RELATED REACTION 11 0.0002
949 ALOPECIA 32 0.0002
950 EYE PAIN 9 0.0002
951 COLITIS 6 0.0002
952 THERAPEUTIC RESPONSE UNEXPECTED 7 0.0002
953 THERAPY NON-RESPONDER 7 0.0002
954 MOVEMENT DISORDER 5 0.0002
955 URTICARIA 26 0.0002
956 ARTHRITIS 12 0.0002
957 EXPIRED PRODUCT ADMINISTERED 5 0.0002
958 BREAST CANCER 14 0.0002
959 COGNITIVE DISORDER 7 0.0001
960 GAIT INABILITY 5 0.0001
961 SUICIDE ATTEMPT 9 0.0001
962 ANXIETY 42 0.0001
963 ARTHROPATHY 8 0.0001
964 INJECTION SITE SWELLING 11 0.0001
965 MOBILITY DECREASED 10 0.0001
966 VISION BLURRED 19 0.0001
967 INFLUENZA LIKE ILLNESS 11 0.0001
968 PARAESTHESIA 21 0.0001
969 DISTURBANCE IN ATTENTION 7 0.0001
970 INJECTION SITE ERYTHEMA 16 0.0001
971 INJURY 9 0.0001
972 NEUROPATHY PERIPHERAL 12 0.0001
973 RENAL CANCER 6 0.0001
974 BLINDNESS 5 0.0001
975 VISUAL IMPAIRMENT 15 0.0001
976 BURNING SENSATION 8 0.0001
977 PROSTATE CANCER 9 0.0001
978 IRRITABILITY 6 0.0001
979 SUICIDAL IDEATION 9 0.0001
980 ANAPHYLACTIC REACTION 5 0.0001
981 ACNE 6 0.0001
982 TOXICITY TO VARIOUS AGENTS 13 0.0001
983 INJECTION SITE HAEMORRHAGE 6 0.0001
984 INJECTION SITE PAIN 23 0.0001
985 INJECTION SITE PRURITUS 5 0.0001
986 TREATMENT FAILURE 6 0.0001
987 COMPLETED SUICIDE 6 0.0001
988 FLUSHING 7 0.0001
989 MUSCULOSKELETAL STIFFNESS 6 0.0001
990 RHEUMATOID ARTHRITIS 7 0.0001